|
Rinvoq goes for psoriatic arthritis approval
|
Thu-16-12-2021, 13:44 PM
Update: AbbVie today announced that the U.S. Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib; 15 mg, once daily) for the treatment of adults with active psoriatic arthritis (PsA) who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers.
|
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Biologic treatments may delay or prevent psoriatic arthritis | Fred | 4 | 537 |
Tue-11-11-2025, 21:22 PM Last Post: Fred |
|
|
Knee pain and psoriatic arthritis | Fred | 2 | 649 |
Thu-09-10-2025, 10:08 AM Last Post: Fred |
|
|
Psoriasis to psoriatic arthritis characterised by alterations in T cells | Fred | 1 | 1,019 |
Wed-17-09-2025, 20:43 PM Last Post: Caroline |
|
|
Tremfya goes for psoriatic arthritis | Fred | 2 | 1,226 |
Thu-21-08-2025, 16:19 PM Last Post: Fred |
|
|
Icotrokinra seeks approval for psoriasis | Fred | 2 | 1,534 |
Fri-25-07-2025, 11:30 AM Last Post: Fred |
Health Boards
